Mirova’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-429
Closed -$222K 134
2024
Q1
$222K Hold
429
0.04% 105
2023
Q4
$202K Sell
429
-25
-6% -$11.6K 0.04% 82
2023
Q3
$198K Sell
454
-786
-63% -$357K 0.04% 87
2023
Q2
$551K Sell
1,240
-1,345
-52% -$620K 0.1% 90
2023
Q1
$1.19M Sell
2,585
-1,500
-37% -$714K 0.17% 83
2022
Q4
$2.1M Buy
4,085
+799
+24% +$406K 0.33% 59
2022
Q3
$1.49M Buy
+3,286
New +$1.57M 0.25% 71
2021
Q4
Sell
-4,553
Closed -$1.7M 189
2021
Q3
$1.7M Buy
4,553
+422
+10% +$160K 0.22% 58
2021
Q2
$1.58M Buy
4,131
+150
+4% +$57.3K 0.19% 56
2021
Q1
$1.43M Buy
3,981
+621
+18% +$200K 0.17% 60
2020
Q4
$1.08M Buy
3,360
+3,022
+894% +$927K 0.14% 58
2020
Q3
$91K Buy
338
+26
+8% +$7K 0.01% 101
2020
Q2
$82K Sell
312
-7
-2% -$1.87K 0.02% 88
2020
Q1
$72K Sell
319
-127
-28% -$34.6K 0.03% 87
2019
Q4
$135K Buy
446
+166
+59% +$45.7K 0.05% 89
2019
Q3
$67K Buy
280
+25
+10% +$6.85K 0.01% 104
2019
Q2
$72K Buy
+255
New +$69.7K 0.01% 99

Other funds holding ELV

Mirova's ELV Position: Q2 2024 in Review

Mirova sold out of Elevance Health (ELV) in Q2 2024, closing a stake of 429 shares — an estimated $222K sold.

Mirova first reported a position in ELV in Q2 2019 and held it in 17 quarters. The position peaked at $2.1M in Q4 2022. 1,705 funds tracked by Wall St. Rank hold ELV as of Q2 2024.

  • Mirova reported no remaining Elevance Health position as of Q2 2024 after selling out during the quarter.
  • Mirova sold 429 Elevance Health shares in Q2 2024, an estimated $222K.
  • Mirova first reported a position in Elevance Health in Q2 2019 and held it in 17 quarters.
  • Mirova's Elevance Health position peaked at $2.1M in Q4 2022.
  • 1,705 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.

Based on Mirova's 13F filing for Q2 2024, filed 13 Aug 2024.